Search

Your search keyword '"CEST"' showing total 1,012 results

Search Constraints

Start Over You searched for: Descriptor "CEST" Remove constraint Descriptor: "CEST"
1,012 results on '"CEST"'

Search Results

51. Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma.

52. Noninvasively differentiating acute and chronic nephropathies via multiparametric urea‐CEST, nuclear Overhauser enhancement‐CEST, and quantitative magnetization transfer MRI.

53. Reassembled saturation transfer (REST) MR images at 2 B1 values for in vivo exchange‐dependent imaging of amide and nuclear Overhauser enhancement.

54. Average saturation efficiency filter ASEF‐CEST MRI of stroke rodents.

55. In vivo pH mapping with omega plot‐based quantitative chemical exchange saturation transfer MRI.

56. Clinically compatible subject‐specific dynamic parallel transmit pulse design for homogeneous fat saturation and water‐excitation at 7T: Proof‐of‐concept for CEST MRI of the brain.

57. Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma.

58. Repeatability of B1+ inhomogeneity correction of volumetric (3D) glutamate CEST via High‐permittivity dielectric padding at 7T.

59. Quasi–steady‐state amide proton transfer (QUASS APT) MRI enhances pH‐weighted imaging of acute stroke.

60. Chemical Exchange Saturation Transfer for Lactate-Weighted Imaging at 3 T MRI: Comprehensive In Silico, In Vitro, In Situ, and In Vivo Evaluations

61. Deep Learning-Based Denoising of CEST MR Data: A Feasibility Study on Applying Synthetic Phantoms in Medical Imaging

62. The Development of a Smart Magnetic Resonance Imaging and Chemical Exchange Saturation Transfer Contrast Agent for the Imaging of Sulfatase Activity

63. Simultaneous pH‐sensitive and oxygen‐sensitive MRI of human gliomas at 3 T using multi‐echo amine proton chemical exchange saturation transfer spin‐and‐gradient echo echo‐planar imaging (CEST‐SAGE‐EPI)

64. Chemical exchange saturation transfer fingerprinting for exchange rate quantification

65. Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study.

66. Assessing the influence of the menstrual cycle on APT CEST-MRI in the human breast.

67. Toward quantitative CEST imaging of glutamate in the mouse brain using a multi-pool exchange model calibrated by 1 H-MRS.

68. Dynamic Glucose Enhanced Imaging using Direct Water Saturation.

69. MRI of GlycoNOE in the human liver using GraspNOE-Dixon.

70. pH Mapping of Gliomas Using Quantitative Chemical Exchange Saturation Transfer MRI: Quasi-Steady-State, Spillover-, and MT-Corrected Omega Plot Analysis.

71. Detecting water-protein chemical exchange in membrane-bound proteins/peptides by solid-state NMR spectroscopy

72. Correction of the post-irradiation T1 relaxation effect for chemical exchange-sensitive MRI: A phantom study

74. Lorentzian-Corrected Apparent Exchange-Dependent Relaxation (LAREX) Ω-Plot Analysis—An Adaptation for qCEST in a Multi-Pool System: Comprehensive In Silico, In Situ, and In Vivo Studies.

75. Two point Dixon-based chemical exchange saturation transfer (CEST) MRI in renal transplant patients on 3 T.

76. Average saturation efficiency filter (ASEF) for CEST imaging.

77. Chemical Exchange Saturation Transfer for Lactate-Weighted Imaging at 3 T MRI: Comprehensive In Silico, In Vitro, In Situ, and In Vivo Evaluations.

78. Towards autonomous analysis of chemical exchange saturation transfer experiments using deep neural networks.

79. Quantitative chemical exchange saturation transfer MRI of intervertebral disc in a porcine model

80. Activation of the Type III Secretion System of Enteropathogenic Escherichia coli Leads to Remodeling of Its Membrane Composition and Function

81. Dynamic Contrast Enhanced-MR CEST Urography: An Emerging Tool in the Diagnosis and Management of Upper Urinary Tract Obstruction

82. Activatable near-infrared fluorescence and chemical exchange saturation transfer MRI multimodal imaging probe for tumor detection in vitro and in vivo.

83. Increasing the accuracy of exchange parameters reporting on slow dynamics by performing CEST experiments with 'high' B1 fields.

84. Comparisons of Glutamate in the Brains of Alzheimer's Disease Mice Under Chemical Exchange Saturation Transfer Imaging Based on Machine Learning Analysis.

85. Evaluating the Cisplatin Dose Dependence of Testicular Dysfunction Using Creatine Chemical Exchange Saturation Transfer Imaging.

86. Learning‐based optimization of acquisition schedule for magnetization transfer contrast MR fingerprinting.

87. AcidoCEST-UTE MRI Reveals an Acidic Microenvironment in Knee Osteoarthritis.

88. Encoding capability prediction of acquisition schedules in CEST MR fingerprinting for pH quantification.

89. Investigation of the Low-Populated Excited States of the HIV-1 Nucleocapsid Domain.

90. Imaging Evaluation of Intervertebral Disc Degeneration and Painful Discs—Advances and Challenges in Quantitative MRI.

91. Dynamic contrast‐enhanced CEST MRI using a low molecular weight dextran.

92. Comparisons of Glutamate in the Brains of Alzheimer’s Disease Mice Under Chemical Exchange Saturation Transfer Imaging Based on Machine Learning Analysis

93. Fast and motion-robust saturation transfer MRI with inherent B 0 correction using rosette trajectories and compressed sensing.

94. Synthesis of higher-B 0 CEST Z-spectra from lower-B 0 data via deep learning and singular value decomposition.

95. Amide Proton Transfer-Weighted MRI, Associations with Clinical Severity and Prognosis in Ischemic Strokes.

96. Simulation, phantom validation, and clinical evaluation of fast pH‐weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST‐EPI) in glioma at 3 T

97. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics

98. 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.

99. What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report.

100. GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas.

Catalog

Books, media, physical & digital resources